Product NDC: | 0517-5602 |
Proprietary Name: | Hydroxyzine Hydrochloride |
Non Proprietary Name: | Hydroxyzine Hydrochloride |
Active Ingredient(s): | 50 mg/mL & nbsp; Hydroxyzine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-5602 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087408 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900930 |
Package NDC: | 0517-5602-25 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-5602-25) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0517-5602-25 |
Proprietary Name | Hydroxyzine Hydrochloride |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-5602-25) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0517-5602 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydroxyzine Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19900930 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | HYDROXYZINE HYDROCHLORIDE |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |